Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

NOTCH3 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

NOTCH3 expression (1)

NOTCH3 expression + ER positive + PGR positive (1)

NOTCH3 overexpression (1)

NOTCH3 underexpression (1)

NOTCH3 expression (1)

NOTCH3 expression + ER positive + PGR positive (1)

NOTCH3 overexpression (1)

NOTCH3 underexpression (1)

›

NOTCH3 mutation	Non Small Cell Lung Cancer	NOTCH3 mutation	Non Small Cell Lung Cancer	tislelizumab-jsgr Sensitive: B - Late Trials tislelizumab-jsgr Sensitive : B	tislelizumab-jsgr Sensitive: B - Late Trials tislelizumab-jsgr Sensitive : B
NOTCH3 mutation	Non Small Cell Lung Cancer	NOTCH3 mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
NOTCH3 mutation	Colorectal Cancer	NOTCH3 mutation	Colorectal Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
NOTCH3 mutation	Solid Tumor	NOTCH3 mutation	Solid Tumor	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3